About
Who We Are
Leadership Team
Board of Directors
Clinical and Scientific Advisors
Contact
Science
Immune Continuum
CCR4 in Inflammation
CCR4 in Cancer
HPK1
Publications
Pipeline
Snapshot
RPT193
FLX475
HPK1
Discovery Programs
Investors & Media
Corporate Profile
Press Releases
Events and Presentations
Stock Information
Corporate Governance
SEC Filings
Email Alerts
Investor Contact
Investor FAQs
Careers
Culture
Benefits
Open Positions
PRESS RELEASES
Year
2023
2022
2021
2020
2019
Filter
March 29 | 2023
RAPT Therapeutics Announces Initiation of Phase 2a Trial of RPT193 in Patients with Moderate-to-Severe Asthma
March 14 | 2023
RAPT Therapeutics Reports Fourth Quarter And Year End Financial Results
February 07 | 2023
RAPT Therapeutics to Participate in the SVB Securities Global Biopharma Conference
January 03 | 2023
RAPT Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
